Insmed
INSM
#964
Rank
โ‚น2.388 T
Marketcap
โ‚น10,937
Share price
-1.29%
Change (1 day)
-14.52%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -โ‚น71.39 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚น1.13 Billion. In 2025 the company made an earning of -โ‚น114.43 Billion a decrease over its 2024 earnings that were of -โ‚น79.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น71.39 Billion-37.62%
2025 -โ‚น114.43 Billion43.91%
2024 -โ‚น79.52 Billion23.71%
2023 -โ‚น64.28 Billion45.77%
2022 -โ‚น44.1 Billion15.83%
2021 -โ‚น38.07 Billion50.19%
2020 -โ‚น25.35 Billion16.4%
2019 -โ‚น21.78 Billion-23.9%
2018 -โ‚น28.62 Billion59.35%
2017 -โ‚น17.96 Billion8.52%
2016 -โ‚น16.55 Billion47.25%
2015 -โ‚น11.24 Billion34.53%
2014 -โ‚น8.36 Billion58.83%
2013 -โ‚น5.26 Billion35.14%
2012 -โ‚น3.9 Billion-31.92%
2011 -โ‚น5.72 Billion854.92%
2010 -โ‚น0.6 Billion-105.22%
2009 โ‚น11.46 B-905.06%
2008 -โ‚น1.43 Billion-27.31%
2007 -โ‚น1.96 Billion-62.41%
2006 -โ‚น5.21 Billion98.19%
2005 -โ‚น2.63 Billion0.03%
2004 -โ‚น2.63 Billion159.07%
2003 -โ‚น1.02 Billion-69.31%
2002 -โ‚น3.31 Billion
2000 -โ‚น2.98 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.487 T-2,056.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-โ‚น187.33 Billion 146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น483.30 B-735.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น12.55 Billion-83.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.23 Billion-97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-โ‚น4.95 Billion-93.49%๐Ÿ‡บ๐Ÿ‡ธ USA